Perspective Therapeutics (CATX) Goodwill & Intangibles (2011 - 2026)
Perspective Therapeutics (CATX) reported Goodwill & Intangibles of $40.0 million for Q1 2026, down 20.0% on a YoY basis from $50.0 million in Q1 2025, and little changed sequentially from $40.0 million in Q4 2025.
Perspective Therapeutics (CATX) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 8 years of Goodwill & Intangibles data on file, last reported at $40.0 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 20.0% year-over-year to $40.0 million; the trailing twelve-month figure through Mar 2026 stood at $40.0 million (down 20.0% YoY), and the FY2025 full-year result was $40.0 million, down 20.0% from the prior year.
- Goodwill & Intangibles steadied at $40.0 million in Q1 2026, from $40.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $77.3 million in Q2 2023 to a low of $40.0 million in Q4 2025.
- A 4-year average of $62.2 million and a median of $74.1 million in 2024 frame the typical range for Goodwill & Intangibles.
- Peak annual rise in Goodwill & Intangibles reached 4.16% in 2024, while the deepest fall reached 32.52% in 2024.
- Tracing CATX's Goodwill & Intangibles over 4 years: stood at $74.1 million in 2023, then tumbled by 32.52% to $50.0 million in 2024, then fell by 20.0% to $40.0 million in 2025, then changed by 0.0% to $40.0 million in 2026.
- Business Quant data shows CATX's Goodwill & Intangibles at $40.0 million in Q1 2026, $40.0 million in Q4 2025, and $50.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Sep 30, 2024 | 74.10 Mn |
| Jun 30, 2024 | 74.10 Mn |
| Mar 31, 2024 | 74.06 Mn |
| Dec 31, 2023 | 74.10 Mn |
| Sep 30, 2023 | 77.32 Mn |
| Jun 30, 2023 | 77.32 Mn |
| Mar 31, 2023 | 77.30 Mn |
| Jun 30, 2015 | 198,490.00 |
| Jun 30, 2014 | 223,756.00 |
| Jun 30, 2012 | 203,256.00 |
| Jun 30, 2011 | 203,194.00 |